Riskpilot← Back to searchSign inGet full accessNORSVIN R&D AS
ASActiveOrg 916197691Storhamargata 44, 2317 HamarResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20150 employees
Revenue 2024
NOK 24,9M
+4% vs 2023
EBITDA margin
11.0%
+50% vs 2023
Equity ratio
65.8%
Financial strength
Net profit 2024
NOK 3M
+34% vs 2023
| Revenue | NOK 24,9M | +4% |
| EBITDA | NOK 2,7M | +50% |
| Net profit | NOK 3M | +34% |
| Total assets | NOK 23,9M | +12% |
| Equity | NOK 15,7M | +23% |
| Employees | 0 | — |
Legal name
NORSVIN R&D AS
Org number
916197691
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
6. november 2015
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Prosjektbasert forskning- og utviklingsarbeid innen avlsforskning på gris.
Address
Storhamargata 44, 2317 Hamar
Email
norsvin@norsvin.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 25 298 | 24 035 | 27 642 | 24 007 | 24 875 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 606 | −212 | 1 315 | 1 822 | 2 725 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 606 | −212 | 1 315 | 1 822 | 2 725 |
| Net financials | 28 | 9 | 97 | 378 | 227 |
| Profit before tax | 633 | −203 | 1 411 | 2 200 | 2 952 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 633 | −203 | 1 411 | 2 200 | 2 952 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 14 273 | 13 688 | 18 338 | 21 386 | 23 893 |
| Equity | 9 367 | 9 164 | 10 575 | 12 775 | 15 726 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 906 | 4 524 | 7 763 | 8 611 | 8 166 |
| Total debt | 4 906 | 4 524 | 7 763 | 8 611 | 8 166 |
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
20202024
Equity ratio
65.8%
This company
38.2%
Market median
+72% vs market
20202024
Return on equity
18.8%
This company
18.4%
Market median
+2% vs market
20202024
Net profit margin
11.9%
This company
8.1%
Market median
+47% vs market
20202024
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
20202024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EH Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2015 | |
| Former (1) | ||
| Board of Directors | 2015 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Norsvin Sa
NORSVIN R&D AS Board members of NORSVIN R&D AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eli Helene Grindflek | Chief Executive Officer | 0 companies |
| Erling Sehested | Board of Directors | 0 companies |
| Torunn Aasmundstad | Board of Directors | 0 companies |
| Olav Eik-Nes | Chairman | 0 companies |